Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-124,956
Closed -$4.89M 393
2021
Q2
$4.89M Sell
124,956
-51,885
-29% -$2.02M 0.21% 102
2021
Q1
$6.41M Sell
176,841
-36,202
-17% -$1.29M 0.22% 101
2020
Q4
$7.84M Sell
213,043
-231,888
-52% -$8.51M 0.24% 97
2020
Q3
$15.5M Sell
444,931
-124,334
-22% -$4.36M 0.38% 72
2020
Q2
$17.7M Sell
569,265
-25,191
-4% -$856K 0.64% 30
2020
Q1
$18.4M Hold
594,456
0.79% 22
2019
Q4
$22.1M Buy
594,456
+3,162
+0.5% +$113K 0.74% 27
2019
Q3
$20.2M Sell
591,294
-15,810
-3% -$575K 0.75% 29
2019
Q2
$25M Sell
607,104
-12,648
-2% -$502K 0.92% 18
2019
Q1
$25M Sell
619,752
-163,370
-21% -$6.54M 0.97% 20
2018
Q4
$32.4M Hold
783,122
1.35% 11
2018
Q3
$32.7M Hold
783,122
1% 15
2018
Q2
$27M Buy
783,122
+87,482
+13% +$2.99M 0.87% 20
2018
Q1
$23.4M Hold
695,640
0.85% 21
2017
Q4
$23.9M Sell
695,640
-36,890
-5% -$1.26M 0.85% 22
2017
Q3
$24.8M Hold
732,530
0.88% 20
2017
Q2
$23.3M Sell
732,530
-60,078
-8% -$1.89M 0.86% 19
2017
Q1
$25.7M Buy
792,608
+44,268
+6% +$1.4M 0.97% 18
2016
Q4
$23.1M Sell
748,340
-31,620
-4% -$965K 0.87% 22
2016
Q3
$25.1M Sell
779,960
-18,972
-2% -$634K 0.97% 19
2016
Q2
$26.7M Hold
798,932
1.06% 15
2016
Q1
$22.5M Buy
798,932
+71,672
+10% +$2.05M 0.91% 22
2015
Q4
$22.3M Sell
727,260
-215,016
-23% -$6.76M 0.91% 23
2015
Q3
$28.1M Sell
942,276
-322,524
-26% -$10.3M 1.26% 13
2015
Q2
$40.2M Hold
1,264,800
1.51% 7
2015
Q1
$41.8M Hold
1,264,800
1.33% 6
2014
Q4
$37.4M Buy
1,264,800
+158,100
+14% +$4.53M 0.95% 13
2014
Q3
$31M Buy
1,106,700
+353,090
+47% +$9.91M 0.9% 12
2014
Q2
$21.2M Sell
753,610
-268,770
-26% -$7.66M 0.67% 18
2014
Q1
$31.2M Sell
1,022,380
-105,400
-9% -$3.14M 1.04% 7
2013
Q4
$32.8M Sell
1,127,780
-115,940
-9% -$3.37M 1.19% 7
2013
Q3
$33.9M Hold
1,243,720
2.02% 5
2013
Q2
$33.1M Buy
+1,243,720
New +$34.4M 2% 4

Other funds holding PFE

BP's PFE Position: Q3 2021 in Review

BP sold out of Pfizer (PFE) in Q3 2021, closing a stake of 124,956 shares — an estimated $4.89M sold.

BP first reported a position in PFE in Q2 2013 and held it in 33 quarters. The position peaked at $41.8M in Q1 2015. 2,804 funds tracked by Wall St. Rank hold PFE as of Q3 2021.

  • BP reported no remaining Pfizer position as of Q3 2021 after selling out during the quarter.
  • BP sold 124,956 Pfizer shares in Q3 2021, an estimated $4.89M.
  • BP first reported a position in Pfizer in Q2 2013 and held it in 33 quarters.
  • BP's Pfizer position peaked at $41.8M in Q1 2015.
  • 2,804 funds tracked by Wall St. Rank held Pfizer as of Q3 2021.

Based on BP's 13F filing for Q3 2021, filed 10 Nov 2021.